{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:28:41Z","timestamp":1788791321002,"version":"build-2803163510"},"reference-count":16,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>The translation of molecular discoveries into clinical benefit remains one of the most significant challenges in contemporary hemato-oncology [...]<\/jats:p>","DOI":"10.3390\/ijms27177932","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:53:28Z","timestamp":1788789208000},"page":"7932","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematological Malignancies: Molecular Mechanisms and Therapy, Second Edition"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-3885","authenticated-orcid":false,"given":"Stella","family":"Bouziana","sequence":"first","affiliation":[{"name":"Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Medicine, King\u2019s College London, London SE5 8AF, UK"},{"name":"Department of Haematology, King\u2019s College Hospital National Health Service (NHS) Foundation Trust, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3324\/haematol.2018.195396","article-title":"Updates on the hematologic tumor microenvironment and its therapeutic targeting","volume":"104","author":"Forte","year":"2019","journal-title":"Haematologica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: Mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101173","DOI":"10.1016\/j.drup.2024.101173","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Di Costanzo, A., Del Gaudio, N., Conte, L., and Altucci, L. (2020). The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options. Cancers, 12.","DOI":"10.3390\/cancers12071898"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3324\/haematol.2022.282442","article-title":"Advances in next-generation sequencing and emerging technologies for hematologic malignancies","volume":"109","author":"Kwon","year":"2024","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","article-title":"From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment","volume":"186","author":"Swanson","year":"2023","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41571-020-0347-5","article-title":"T cell-engaging therapies\u2014BiTEs and beyond","volume":"17","author":"Goebeler","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","first-page":"2307","article-title":"Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma","volume":"141","author":"Neelapu","year":"2023","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103096","DOI":"10.1016\/j.critrevonc.2020.103096","article-title":"Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy","volume":"157","author":"Bouziana","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bouziana, S. (2025). Hematological Malignancies: Molecular Mechanisms and Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062438"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eaal1571","DOI":"10.1126\/scitranslmed.aal1571","article-title":"Microenvironmental regulation of the IL-23R\/IL-23 axis overrides chronic lymphocytic leukemia indolence","volume":"10","author":"Cutrona","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3324\/haematol.2022.280638","article-title":"Measurable residual disease in acute lymphoblastic leukemia: Methods and clinical context in adult patients","volume":"107","author":"Saygin","year":"2022","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e71205","DOI":"10.1002\/cam4.71205","article-title":"Prevalence of Fms-Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta-Analysis","volume":"14","author":"Lewis","year":"2025","journal-title":"Cancer Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Negotei, C., Colita, A., Mitu, I., Lupu, A.R., Lapadat, M.-E., Popovici, C.E., Crainicu, M., Stanca, O., and Berbec, N.M. (2023). A Review of FLT3 Kinase Inhibitors in AML. J. Clin. Med., 12.","DOI":"10.3390\/jcm12206429"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7932\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:54:48Z","timestamp":1788789288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":16,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177932"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177932","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]}}}